You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 201861 - 201870 of 207725 results
  1. Virtual Reality Cue Reactivity for Alcohol Dependence

    SBC: VIRTUALLY BETTER INC            Topic: N/A

    DESCRIPTION (provided by applicant): Advances in Virtual Reality (VR), and the integration of realistic video images into VR environments, are being used to create usable simulations that are being employed clinically for the treatment of anxiety disorder

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  2. Dual Purpose b-Lactamase Inhibitors

    SBC: DESIGN THERAPEUTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The ability to produce one or more b-lactamases represents the most common form of bacterial resistance to the b-lactam antibiotics. One successful method of countering such resistance is the co-administration of a b-

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  3. Efficacy of Liposomal Budesonide in Experimental Asthma

    SBC: VGSK, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Asthma is the most common chronic illness in childhood and affects 5 to 10% of the population. The disease is characterized by acute bronchoconstriction, chronic inflammation, and airway remodeling which may lead t

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  4. Molecular tools for Bunyavirus antiviral screening

    SBC: APATH, LLC            Topic: N/A

    DESCRIPTION (provided by investigator): Several viruses in the family Bunyaviridae are significant human pathogens and potential agents of bioterrorism. Vaccines against some of these viruses do exist, but with the exception of ribavarin, there are no

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  5. Biomolecule Crystallization Microarray

    SBC: SPACE HARDWARE OPTIMIZATION TECHNOLOGY            Topic: N/A

    DESCRIPTION (provided by applicant): Several aspects of health and medicinal research depend on the knowledge of macromolecular structures, the determination of which depends on a supply of high-quality crystals. Conditions for growing high-quality crys

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  6. GHRH TREATMENT OF HEART FAILURE

    SBC: CARDIOVASCULAR BIOSCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Heart failure is the leading cause of combined morbidity and mortality in the United States and other developed industrial nations. It remains an incurable disease process with an estimated two-year mortality of 30-50%

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  7. Nonpeptide Somatostatin Agonists for Retinopathy

    SBC: SOMATOCOR PHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Diabetic retinopathy (DR), the leading cause of adult blindness in the United States, is characterized by aberrant neovascularization ultimately leading to blindness. Similarly, choroidal neovascularization is seen in

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  8. Cloning and Engineering of Nicking enzymes

    SBC: NEW ENGLAND BIOLABS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): This proposal is aimed towards cloning, expression and engineering of DNA nicking enzymes. Two nicking enzymes CviNY2A and CviNYSI have been found in Chlorella-like algae virus strains NY2A and NYSI with three-nucleoti

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  9. Data acquisition system for noninvasive cancer detection

    SBC: Biophotonics Corporation            Topic: N/A

    DESCRIPTION (provided by applicant): The overall goal of the proposal is to develop an automated data acquisition system for non-invasive quantitative cancer detection, screening, and monitoring, based on highly sensitive low volume real time PCR techn

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  10. Heterologous Production of Eleutherobin Precursors

    SBC: AMYRIS BIOTECHNOLOGIES            Topic: N/A

    DESCRIPTION (provided by applicant): Terpenoids are a diverse class of natural compounds with equally diverse and potent bioactivities. Because the practical use of terpenoids hinges on the ability to extract or synthesize these compounds, only the most a

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government